☰

Priya Prahalad, Ph.D. - Publications

Affiliations: 
2010 Cell Biology Georgetown University, Washington, DC 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Prahalad P, Hardison H, Odugbesan O, Lyons S, Alwazeer M, Neyman A, Miyazaki B, Cossen K, Hsieh S, Eng D, Roberts A, Clements MA, Ebekozien O. Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers. Clinical Diabetes : a Publication of the American Diabetes Association. 42: 27-33. PMID 38230344 DOI: 10.2337/cd23-0052  0.333
2023 Prahalad P, Maahs DM. Roadmap to Continuous Glucose Monitoring Adoption and Improved Outcomes in Endocrinology: The 4T (Teamwork, Targets, Technology, and Tight Control) Program. Diabetes Spectrum : a Publication of the American Diabetes Association. 36: 299-305. PMID 37982062 DOI: 10.2337/dsi23-0003  0.35
2023 Zaharieva DP, Ding V, Addala A, Prahalad P, Bishop F, Hood K, Desai M, Wilson DM, Buckingham BA, Maahs DM. Diabetic ketoacidosis (DKA) at diagnosis in youth with type 1 diabetes (T1D) is associated with a higher hemoglobin A1c even with intensive insulin management. Diabetes Technology & Therapeutics. PMID 37955644 DOI: 10.1089/dia.2023.0405  0.316
2023 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, ... Prahalad P, et al. Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48. Diabetes Care. PMID 37356031 DOI: 10.2337/dc23-ad08a  0.304
2023 Addala A, Ding V, Zaharieva DP, Bishop FK, Adams AS, King AC, Johari R, Scheinker D, Hood KK, Desai M, Maahs DM, Prahalad P. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring. Jama Network Open. 6: e238881. PMID 37074715 DOI: 10.1001/jamanetworkopen.2023.8881  0.363
2023 Huang J, Yeung AM, DuBord AY, Wolpert H, Jacobs PG, Lee WA, Drincic A, Spanakis EK, Sherr JL, Prahalad P, Fleming A, Hsiao VC, Kompala T, Lal RA, Fayfman M, et al. Diabetes Technology Meeting 2022. Journal of Diabetes Science and Technology. 19322968221148743. PMID 36704821 DOI: 10.1177/19322968221148743  0.317
2022 Corathers S, Wilford D, Kichler J, Smith L, Ospelt E, Rompicherla S, Roberts A, Prahalad P, Basina M, Muñoz C, Ebekozien O. Implementation of Psychosocial Screening into Diabetes Clinics: Experience from the Type 1 Diabetes Exchange Quality Improvement Network. Current Diabetes Reports. PMID 36538250 DOI: 10.1007/s11892-022-01497-6  0.331
2022 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, ... Prahalad P, et al. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care. 46: S41-S48. PMID 36507633 DOI: 10.2337/dc23-S003  0.301
2022 Dupenloup P, Pei RL, Chang A, Gao MZ, Prahalad P, Johari R, Schulman K, Addala A, Zaharieva DP, Maahs DM, Scheinker D. A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care. Frontiers in Endocrinology. 13: 1021982. PMID 36440201 DOI: 10.3389/fendo.2022.1021982  0.301
2022 Tanenbaum ML, Zaharieva DP, Addala A, Prahalad P, Hooper JA, Leverenz B, Cortes AL, Arrizon-Ruiz N, Pang E, Bishop F, Maahs DM. 'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis. Diabetic Medicine : a Journal of the British Diabetic Association. e14923. PMID 35899591 DOI: 10.1111/dme.14923  0.35
2022 Scheinker D, Gu A, Grossman J, Ward A, Ayerdi O, Miller D, Leverenz J, Hood K, Lee MY, Maahs DM, Prahalad P. Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice. Jmir Diabetes. 7: e27284. PMID 35666570 DOI: 10.2196/27284  0.349
2022 Lee MY, Tanenbaum ML, Maahs DM, Prahalad P. Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action. Case Reports in Endocrinology. 2022: 9911736. PMID 35273814 DOI: 10.1155/2022/9911736  0.331
2022 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, ... Prahalad P, et al. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care. 45: S39-S45. PMID 34964876 DOI: 10.2337/dc22-S003  0.303
2021 Prahalad P, Schwandt A, Besançon S, Mohan M, Obermannova B, Kershaw M, Bonfanti R, Lyckå AP, Hanas R, Casteels K. Hemoglobin A1c trajectories in the first 18 months after diabetes diagnosis in the SWEET diabetes registry. Pediatric Diabetes. 23: 228-236. PMID 34779090 DOI: 10.1111/pedi.13278  0.317
2021 Nguyen KT, Xu NY, Zhang JY, Shang T, Basu A, Bergenstal RM, Castorino K, Chen KY, Kerr D, Koliwad SK, Laffel LM, Mathioudakis N, Midyett LK, Miller JD, Nichols JH, ... ... Prahalad P, et al. Continuous Ketone Monitoring Consensus Report 2021. Journal of Diabetes Science and Technology. 19322968211042656. PMID 34605694 DOI: 10.1177/19322968211042656  0.32
2021 Addala A, Zaharieva DP, Gu AJ, Prahalad P, Scheinker D, Buckingham B, Hood KK, Maahs DM. Clinically serious hypoglycemia is rare and not associated with time-in-range in youth with new-onset type 1 diabetes. The Journal of Clinical Endocrinology and Metabolism. PMID 34265059 DOI: 10.1210/clinem/dgab522  0.337
2021 Lee J, Carlson E, Albanese-O'Neill A, Demeterco Berggren C, Corathers S, Vendrame F, Weinstock RS, Prahalad P, Alonso GT, Kamboj MK, DeSalvo DJ, Malik F, Izquierdo R, Ebekozien O. Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic. Diabetes Technology & Therapeutics. PMID 33851873 DOI: 10.1089/dia.2021.0080  0.303
2020 Prahalad P, Zaharieva DP, Addala A, New C, Scheinker D, Desai M, Hood KK, Maahs DM. Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control-The 4T Study. Frontiers in Endocrinology. 11: 360. PMID 32733375 DOI: 10.3389/Fendo.2020.00360  0.42
2020 Addala A, Maahs DM, Scheinker D, Chertow S, Leverenz B, Prahalad P. Uninterrupted Continuous Glucose Monitoring Access is Associated with a Decrease in HbA1c in Youth with Type 1 Diabetes and Public Insurance. Pediatric Diabetes. PMID 32681582 DOI: 10.1111/Pedi.13082  0.386
2020 Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Jama. 323: 2388-2396. PMID 32543683 DOI: 10.1001/Jama.2020.6940  0.373
2020 Grossman J, Ward AT, Maahs DM, Prahalad P, Scheinker D. 872-P: Improved HbA1c Estimation Using CGM Data Diabetes. 69. DOI: 10.2337/Db20-872-P  0.405
2020 Lal R, Moeller HP, Freeman R, Prahalad P, Annes JP. 1801-P: Novel De Novo INS P.T97P Variant Presenting with Severe Neonatal DKA Diabetes. 69. DOI: 10.2337/Db20-1801-P  0.346
2020 Rioles N, Bunker C, Clements MA, Gallagher K, Garrity A, Jones N, Kamboj MK, Majidi S, Prahalad P, Sonabend RY, Thivener K, Ebekozien O. 150-LB: Moving the Needle on the High-Risk T1D Panel: Lessons from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) Diabetes. 69. DOI: 10.2337/Db20-150-Lb  0.397
2020 Ebekozien O, Rioles N, Desalvo D, Gallagher K, Lee JM, Mcdonough R, Obrynba K, Prahalad P, Thomas S, Weinstock RS, Corathers S. 145-LB: Improving Continuous Glucose Monitoring (CGM) Use across Ten National Centers: Results from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) Diabetes. 69. DOI: 10.2337/Db20-145-Lb  0.427
2020 Prahalad P, Ding V, Addala A, New C, Conrad BP, Chmielewski A, Geels E, Leverenz J, Martinez-Singh A, Sagan P, Senaldi J, Freeman A, Scheinker D, Hood KK, Desai M, et al. 1297-P: Early CGM Initiation Improves HbA1c in T1D Youth over the First 15 Months Diabetes. 69. DOI: 10.2337/Db20-1297-P  0.419
2020 Zaharieva D, Prahalad P, Addala A, Scheinker D, Desai M, Hood KK, Leverenz B, Maahs DM. 1295-P: Newly Diagnosed Pediatric Patients with Type 1 Diabetes Show Steady Decline in Glucose Time-in-Range (TIR) over 1 Year: Pilot Study Diabetes. 69. DOI: 10.2337/Db20-1295-P  0.39
2020 Gu A, Prahalad P, Maahs DM, Addala A, Scheinker D. 1289-P: The Association between Time-in-Range, Mean Glucose, and Incidence of Hypoglycemia in Youth with Newly Diagnosed T1D Diabetes. 69. DOI: 10.2337/Db20-1289-P  0.432
2020 Lee MY, Leverenz J, Leverenz B, Pageler NM, Scheinker D, Maahs DM, Prahalad P. 1281-P: Pilot Study on the Feasibility of Weekly CGM Data Review in Youth with New-Onset Type 1 Diabetes Diabetes. 69. DOI: 10.2337/Db20-1281-P  0.466
2020 Vallon J, Ward AT, Prahalad P, Hood KK, Maahs DM, Scheinker D. 1185-P: A Telemedicine-CGM Recommendation System for Personalized Population Health Management Diabetes. 69. DOI: 10.2337/Db20-1185-P  0.428
2019 Prahalad P, Addala A, Scheinker D, Hood KK, Maahs DM. CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time. Diabetes Care. PMID 31558548 DOI: 10.2337/Dc19-1205  0.454
2019 Prahalad P, Yang J, Scheinker D, Desai M, Hood K, Maahs DM. Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes. Diabetes Technology & Therapeutics. PMID 31180244 DOI: 10.1089/Dia.2019.0065  0.433
2019 PRAHALAD P, SCHEINKER D, HOOD KK, BUCKINGHAM BA, WILSON DM, CHMIELEWSKI A, CONRAD BP, GEELS E, LEVERENZ J, PETERSON K, MAAHS DM. 1358-P: Early CGM Initiation in New-Onset Type 1 Diabetes Patients Diabetes. 68: 1358-P. DOI: 10.2337/Db19-1358-P  0.441
2019 Cabrera AB, Alonso GT, Corathers S, Lee JM, Prahalad P, Rioles N. 1261-P: Assessing Data Availability and Benchmarking Performance of Quality Measures for the T1D Exchange Quality Improvement Collaborative Diabetes. 68. DOI: 10.2337/Db19-1261-P  0.351
2018 King F, Klonoff DC, Ahn D, Adi S, Berg EG, Bian J, Chen K, Drincic A, Heyl M, Magee M, Mulvaney S, Pavlovic Y, Prahalad P, Ryan M, Sabharwal A, et al. Diabetes Technology Society Report on the FDA Digital Health Software Precertification Program Meeting. Journal of Diabetes Science and Technology. 1932296818810436. PMID 30394807 DOI: 10.1177/1932296818810436  0.309
2018 Prahalad P, Addala A, Buckingham B, Wilson DM, Maahs DM. Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All. Diabetes Technology & Therapeutics. PMID 30020810 DOI: 10.1089/Dia.2018.0204  0.406
2018 Prahalad P, Tanenbaum M, Hood K, Maahs DM. Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabetic Medicine : a Journal of the British Diabetic Association. 35: 419-429. PMID 29356074 DOI: 10.1111/Dme.13588  0.419
2018 PRAHALAD P, BUCKINGHAM B, WILSON D, MAAHS DM. Sustained CGM Use in Low Income Youth following Insurance Coverage Diabetes. 67: 1390-P. DOI: 10.2337/Db18-1390-P  0.446
2018 WOOD J, BOYLE C, QUINN M, WONG JC, HALLER MJ, NELSON BA, HALLER MJ, SCHATZ D, TAMBORLANE WV, FOX L, PRAHALAD P, CORATHERS S, MAAHS DM, ALONSO GT, DESALVO DJ, et al. Impact of Target HbA1c Change in Pediatric Participants in the T1D Exchange Clinic Registry Diabetes. 67: 1373-P. DOI: 10.2337/Db18-1373-P  0.349
2010 Prahalad P, Dakshanamurthy S, Ressom H, Byers SW. Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells. Plos One. 5: e10023. PMID 20386594 DOI: 10.1371/Journal.Pone.0010023  0.471
2008 Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. Plos One. 3: e2714. PMID 18628953 DOI: 10.1371/Journal.Pone.0002714  0.466
Show low-probability matches.